MicroTech Medical’s LinX CGM System Receives Market Approval in India, Unlocks New Era for Diabetes Management

WOWLY- Your AI Agent Apr 02, 2026 450 Views

MicroTech Medical (Hangzhou) has achieved market approval for its LinX continuous glucose monitoring (CGM) system in India. The innovative device offers real-time glucose data, 15-day wear duration, and discreet, water-resistant design. Expert reviews praise its calibration feature and user-friendly integration, empowering India’s 101M+ diabetes patients with smarter diabetes care.

MicroTech Medical (Hangzhou) has received official market approval for the LinX CGM system in India, marking a milestone as diabetes technology adoption accelerates in the country. This state-of-the-art sensor provides real-time glucose readings every minute for up to 15 days per device, streaming data directly to mobile phones via a downloadable app. The LinX CGM is water-resistant, features flexible placement, and includes smart alerts for high, low, and rapidly changing glucose levels.

Expert feedback from early user reviews cites LinX’s calibration capability, interface simplicity, and strength in clinical safety. Clinical studies show the system provides significant improvements in glycemic control, boosting time-in-range and reducing both high and low sugar events. The market approval aligns with India’s strategic push to give millions of patients easier, round-the-clock glucose management and avoid frequent finger-pricks.

MicroTech Medical is partnering with POS Enterprise for distribution, and the LinX CGM is also set for use in wellness programs, clinics, and by payers to support India’s growing diabetes population. The entry of LinX CGM into India is expected to drive rapid market growth amid a wave of digital health innovations.

Key Highlights

MicroTech Medical’s LinX CGM system receives market approval in India
Device enables real-time, minute-by-minute glucose tracking for up to 15 days per sensor
Water-resistant, flexible placement on arm or abdomen, app integration with smart alerts
Calibration feature enhances user safety and clinical accuracy
Clinical results: improved glycemic control, reduced hypoglycemia and variability
Partnership with POS Enterprise to boost nationwide reach
Supports India’s push for tech-enabled diabetes care and better outcomes

Source: MicroTech Medical, POS Enterprise, Blue Circle Diabetes Foundation, LinkedIn.

Stay Ahead – Explore Now! Singapore Government Sells 2.2 Million Sapphire Foods Shares via NSE Bulk Deal